EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtLeitlinieOpen Access · CC BY-NC 4.0

Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis

Ryu Watanabe, Megumi Oshima, Norihiro Nishioka, Ken-Ei Sada, Kenji Nagasaka, Mitsuhiro Akiyama, Taiki Ando, Tomoaki Higuchi, Yoshino Inoue, Takashi Kida, Tomoyuki Mutoh, Akihiko Nakabayashi und 8 weitere

Modern Rheumatology · 2023

DOI: 10.1093/mr/roac114 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Ryu Watanabe und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Azathioprine, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health, Labour, and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objective of this study is to provide evidence for the revision of clinical practice guidelines for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis by the Japan Research Committee for Intractable Vasculitis.

Methods

PubMed, CENTRAL, and the Japan Medical Abstracts Society databases were searched for articles published between 2015 and 2020 to update the systematic review for existing clinical questions, while PubMed, CENTRAL, EMBASE, and the Japan Medical Abstracts Society were searched for articles published between 2000 and 2020 to conduct a systematic review for newly developed clinical questions. The certainty of evidence was assessed with the GRADE approach.

Results

For remission induction, when used in conjunction with cyclophosphamide or rituximab, reduced-dose glucocorticoid lowered the risk of serious adverse events compared to standard-dose glucocorticoid. Avacopan improved sustained remission at 12 months compared to high-dose glucocorticoid. Addition of plasma exchange to remission induction therapy did not reduce the risk of death, end-stage kidney disease, or relapse. For remission maintenance, rituximab reduced the risk of relapse compared to azathioprine. Long-term rituximab or azathioprine reduced the risk of relapse compared to short-term rituximab or azathioprine, respectively.

Conclusions

This systematic review provided evidence required to develop the 2023 clinical practice guideline for the management of ANCA-associated vasculitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzathioprineAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisHumansImmunosuppressive AgentsRituximabGlucocorticoidsJapanRemission InductionAntibodies, Antineutrophil CytoplasmicRecurrence

Stichwörter der Autor:innen

ANCA-associated vasculitisGRADE systemgranulomatosis with polyangiitismicroscopic polyangiitissystematic review

Substanzen

AzathioprineImmunosuppressive AgentsRituximabGlucocorticoidsAntibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan.
  • Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Okayama University, Okayama, Japan.
  • Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku, Japan.
  • Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan.

ORCID-Profile: Masayoshi Harigai

Förderung

  • Ministry of Health, Labour, and Welfare of Japan

Zitieren

APA

Watanabe, R., Oshima, M., Nishioka, N., Sada, K. E., Nagasaka, K., Akiyama, M., Ando, T., Higuchi, T., Inoue, Y., Kida, T., Mutoh, T., Nakabayashi, A., Onishi, A., Sakai, R., Waki, D., Yamada, Y., Yajima, N., Tamura, N., Kaname, S., & Harigai, M. (2023). Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis. Modern Rheumatology. https://doi.org/10.1093/mr/roac114

Vancouver

Watanabe R, Oshima M, Nishioka N, Sada KE, Nagasaka K, Akiyama M, et al. Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis. Modern Rheumatology. 2023. doi:10.1093/mr/roac114

BibTeX
@article{Watanabe2023,
  author = {Watanabe, Ryu and Oshima, Megumi and Nishioka, Norihiro and Sada, Ken-Ei and Nagasaka, Kenji and Akiyama, Mitsuhiro and Ando, Taiki and Higuchi, Tomoaki and Inoue, Yoshino and Kida, Takashi and Mutoh, Tomoyuki and Nakabayashi, Akihiko and Onishi, Akira and Sakai, Ryota and Waki, Daisuke and Yamada, Yosuke and Yajima, Nobuyuki and Tamura, Naoto and Kaname, Shinya and Harigai, Masayoshi},
  title = {Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis},
  journal = {Modern Rheumatology},
  year = {2023},
  doi = {10.1093/mr/roac114}
}
Kostenlos starten →